Upper Tract Urothelial Carcinoma Clinical Trial
Official title:
Phase I Study of WST11 Phototherapy for Upper Tract Urothelial Carcinoma
The purpose of this study is to test the safety of a combination of the study drug called WST11 and PDT. Photodynamic therapy (PDT) is a type of ablation therapy (treatment which destroys tumor cells) which has been previously approved for the treatment of patients with other cancers. It works by using a drug that is given through the vein and then is activated in the tumor by light administered during endoscopy, which results in destruction of the cancer cells.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02547350 -
Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas
|
Phase 2 | |
Recruiting |
NCT04948528 -
Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for Upper Tract Urothelial Carcinoma Detection
|
||
Recruiting |
NCT05917158 -
A Study of RC48-ADC Combined With JS001 For Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma
|
Phase 2 | |
Recruiting |
NCT02923557 -
Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients
|
Phase 2 | |
Recruiting |
NCT02969083 -
Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma
|
Phase 2 | |
Recruiting |
NCT03544437 -
Feasibility and Safety of Extraperitoneal Laparoscopic Extended Retroperitoneal Lymph Node Dissection at Time of Nephroureterectomy for Upper Tract Urothelial Carcinoma
|
||
Recruiting |
NCT03230201 -
Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma)
|
N/A | |
Recruiting |
NCT02740426 -
Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients
|
Phase 2 |